Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,130.00
(
0.48%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
100.59
(
-0.06%
)
Bitcoin
74,058.72
(
0.16%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Icebreaker

Send PM Follow Ignore
Followers 0
Posts 10
Boards Moderated 0
Alias Born 06/30/2006

Icebreaker

Re: biomaven0 post# 149071

Thursday, 09/20/2012 8:13:21 PM

Thursday, September 20, 2012 8:13:21 PM

Post# of 257253
"Bristol's PD-1 program is certainly pretty exciting in the oncology space."

I realize it is a long shot, but it seems to me that Pfizer must be thinking about taking out Bristol. They would gain 100% of Eliquis and they would gain maybe the best asset in oncology Anti PD-1.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now